Computerized tomography in chronic thromboembolic pulmonary hypertension

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Heart (British Cardiac Society)·2003

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001

Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.

Journal of thrombosis and thrombolysis·2001

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

American heart journal·2001

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

American heart journal·2001

Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution.

Journal of thrombosis and thrombolysis·2001

Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.

American heart journal·2026

Pregnancy Outcomes in Women with a History of Myocarditis.

American heart journal·2026

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

American heart journal·2026

Efficacy and safety of revascularization in patients with chronic limb-threatening ischemia by kidney function.

American heart journal·2026

Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor-neprilysin inhibition in acute heart failure: insights from the PREMIER study.

American heart journal·2026

Reconsidering Fibrinolysis in Selected Patients with Non-ST-Elevation Acute Coronary Syndrome: A Hypothesis-Generating, Research-Based Framework.

American heart journal·2026

MMP-9 Gene Ablation Preserves Ejection Fraction During "Single-Hit" Model of HFrEF.

Biochemical genetics·2026

Decoding Leukocyte Dynamics: Functional Biomarkers and Precision Diagnostics in Parasitic Infections.

Acta parasitologica·2026

Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.

Clinical research in cardiology : official journal of the German Cardiac Society·2026

Acute Myocarditis: From Pathophysiology to Risk-Stratified Management-A Clinical Review.

European journal of clinical investigation·2026

Agreement Between Standard and Right Ventricular-Focused Apical Four-Chamber Views for Right Ventricular Longitudinal Functional Indices: A Within-Participant Agreement Study.

Echocardiography (Mount Kisco, N.Y.)·2026

Targeted metabolomic profiling and machine learning-based prediction models for persistent atrial fibrillation: a multi-center observational study.

PeerJ·2026

Related Experiment Videos

Computerized tomography in chronic thromboembolic pulmonary hypertension

Related Concept Videos

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.

Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution.

Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.

Pregnancy Outcomes in Women with a History of Myocarditis.

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

Efficacy and safety of revascularization in patients with chronic limb-threatening ischemia by kidney function.

Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor-neprilysin inhibition in acute heart failure: insights from the PREMIER study.

Reconsidering Fibrinolysis in Selected Patients with Non-ST-Elevation Acute Coronary Syndrome: A Hypothesis-Generating, Research-Based Framework.

MMP-9 Gene Ablation Preserves Ejection Fraction During "Single-Hit" Model of HFrEF.

Decoding Leukocyte Dynamics: Functional Biomarkers and Precision Diagnostics in Parasitic Infections.

Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.

Acute Myocarditis: From Pathophysiology to Risk-Stratified Management-A Clinical Review.

Agreement Between Standard and Right Ventricular-Focused Apical Four-Chamber Views for Right Ventricular Longitudinal Functional Indices: A Within-Participant Agreement Study.

Targeted metabolomic profiling and machine learning-based prediction models for persistent atrial fibrillation: a multi-center observational study.

Related Experiment Videos

Computerized tomography in chronic thromboembolic pulmonary hypertension

Related Concept Videos

Related Articles